Phase Genomics raised $1.5M in funding led by Bill & Melinda Gates Foundation to develop a new antimicrobial discovery platform.
Phase Genomics raised $1.5M in funding led by Bill & Melinda Gates Foundation to develop a new antimicrobial discovery platform.
03/05/24, 7:52 PM
Location
seattleMoney raised
$1.5 million
Industry
science and engineering
data and analytics
Round Type
seed
Investors
Bill & Melinda Gates Foundation
Phase Genomics, a genomics technology development company based in Seattle, WA, raised $1.5M in funding. The funding was provided by the Bill & Melinda Gates Foundation. The company intends to use the funds to develop a new antimicrobial discovery platform.
Company Info
Location
4000 mason road
seattle, washington, united states
Additional Info
Phase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software.
Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company’s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.